Not exact matches
«We also confirmed a role in PDAC
tumor maintenance as inhibition of PRMT1 in patient -
derived mouse
models significantly inhibited
tumor growth and extended survival,» said Giuliani.
Using human -
derived glioblastoma cells in a mouse
models, researchers found that the modified high - fat, low - carbohydrate diet increased life expectancy by 50 percent while also reducing
tumor progression by a similar amount.
In collaboration with the group of Valerian Kagan, Ph.D., D.Sc., at the University of Pittsburgh, Gabrilovich and colleagues analyzed in great detail the events that take place in the DCs from
tumor - bearing mice
models and found that impaired cross-presentation, which occurred in the presence of
tumor -
derived factors, was associated with defective trafficking of the antigen - MHC complex to the cell surface.
EZH2 inhibition delayed
tumor onset in KDM6A - null cells and caused regression of KDM6A - null bladder
tumors in both patient -
derived and cell line xenograft
models.
«In mammalian cells we have only been able to study ALT in cells
derived from ALT - dependent
tumors,» says Karlseder, who also employs roundworm
models to test ALT - dependent telomere construction.
Meng and Nel also collaborated with Dr. Timothy Donahue, chief of gastrointestinal and pancreatic surgery and a Jonsson Comprehensive Cancer Center member, to demonstrate that treatment with the iRGD peptide can enhance
tumor cell killing for patient -
derived pancreatic cancers, growing subcutaneously in a mouse
model.
These inhibitors effectively targeted and blocked Msi expressing cells, resulting in halted
tumor growth in animal
models as well as in patient -
derived cancer cells, which harbor more complex mutations and are uniformly drug - resistant.
«Preclinical results support entinostat's role in targeting the
tumor microenvironment: Entinostat inhibits function of myeloid
derived suppressor cells resulting in enhanced antitumor effect in murine
models of lung and renal cell carcinoma.»
They found that injecting patient -
derived, brain - seeking melanoma cells into the carotid artery of these preclinical
models resulted in the formation of many metastatic
tumors throughout the brain, mimicking what is seen in advanced melanoma cancer patients.
The researchers used an in vivo
model of PARP inhibitor resistance in patient -
derived tumor xenografts (PDXs).
NCI's efforts to develop new laboratory
models of human cancer includes vastly increasing the number of human cancer cell lines (grown as two - dimensional and three - dimensional cultures) and patient -
derived tumor xenografts.
Establishing a repository of laboratory
models derived from patient
tumor samples that will enable researchers to more thoroughly investigate drug resistance
To evaluate
tumor growth in mice of each genotype, we used an orthotopic implant
model derived from a spontaneous pancreatic
tumor arising in a C57BL / 6 KPC mouse (33), which expresses mutant forms of K - Ras and p53 selectively in pancreatic tissue.
Finally, I have a category of «other cancers» with exomes published in 2011; these include pancreastic cysts and cell lines, gastric cancer
tumors, and prostate cancer samples
derived through mouse xenograft
models.
This includes the generation of animal
models containing patient -
derived tumor tissue to evaluate the sensitivity of genomically targeted drugs.
Liu JF, Palakurthi S, Zeng Q, Zhou S, Ivanova E, Huang W, Zervantonakis IK, Selfors LM, Shen Y, Pritchard CC, Zheng M, Adleff V, Papp E, Piao H, Novak M, Fotheringham S, Wulf G, English J, Kirschmeier PT, Velculescu VE, Paweletz CP, Mills GB, Livingston DM, Brugge JS, Matulonis UA, Drapkin R.: Establishment of patient -
derived tumor xenograft
models of epithelial ovarian cancer for pre-clinical evaluation of novel therapeutics.
Although this possibility has not yet attracted as much attention as the ideas of cell replacement, personalized medicine and other more direct clinical applications, hESCs are expected to be superior to most commonly used cell - culture
models of drug discovery which employ
tumor -
derived or immortalized cell lines or primary cell culture.
The approach is to use clinically relevant
tumor models such as patient -
derived xenografts (PDXs), as well as humanized and immunocompetent transgenic
tumor - bearing mice to design rational combinations of novel and emerging cancer therapies, including
tumor - targeting and immune - stimulating therapies, to ultimately improve treatment outcomes for cancer patients.
These platforms include genetically engineered mouse (GEM)
models, fallopian tube -
derived cell lines, and patient -
derived tumor xenografts.
Over 170 carefully curated, well - characterized patient -
derived xenograft
tumor models are available for use in your facility, or use Horizon's comprehensive preclinical in vivo efficacy service.